Environmental Laboratory
Test Medical Cannabis Potency with Greater Accuracy Using New DEA-Exempted CBDA Certified Reference Material
Jan 16 2017
As part of our commitment to the emerging industry of medical cannabis analysis, Restek has expanded its selection of cannabinoid-related reference standards by adding cannabidiolic acid (CBDA). This 1,000 ppm standard is DEA-exempted, so there’s no need to purchase costly neat materials or to make your own standards, and it is prepared in acetonitrile, which helps maintain stability by preventing methylation of the carboxylic acid group on the molecule. Paired with Restek’s THC standards, it is perfect for the analysis of both neutrals and acids in cannabis products by LC and is a must for accurate quantification in medical cannabis potency testing and strain ID. Restek’s CBDA standard is also a certified reference material (CRM) so you know that it meets strict ISO quality requirements.
From potency to pesticides analysis, Restek offers the LC and GC chromatography columns, CRMs, accessories, and sample prep supplies—as well as technical literature and support—needed for accurate, reliable medical marijuana analysis. Learn more about Restek’s products and resources at www.restek.com/medical-cannabis and start growing your medical cannabis testing business today.
Digital Edition
AET 28.2 April/May 2024
May 2024
Business News - Teledyne Marine expands with the acquisition of Valeport - Signal partners with gas analysis experts in Korea Air Monitoring - Continuous Fine Particulate Emission Monitor...
View all digital editions
Events
Jul 10 2024 Birmingham, UK
Jul 21 2024 Cape Town, South Africa
Australasian Waste & Recycling Expo
Jul 24 2024 Sydney, Australia
Jul 30 2024 Jakarta, Indonesia
China Energy Summit & Exhibition
Jul 31 2024 Beijing, China